DongKoo Bio&Pharma Co. Ltd (006620) - Total Liabilities

Latest as of September 2025: ₩158.34 Billion KRW ≈ $107.31 Million USD

Based on the latest financial reports, DongKoo Bio&Pharma Co. Ltd (006620) has total liabilities worth ₩158.34 Billion KRW (≈ $107.31 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

DongKoo Bio&Pharma Co. Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how DongKoo Bio&Pharma Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See 006620 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

DongKoo Bio&Pharma Co. Ltd Competitors by Total Liabilities

The table below lists competitors of DongKoo Bio&Pharma Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Yeong Guan Energy Technology Group Co Ltd TW:1589	Taiwan	NT$17.93 Billion
Rockwell Medical Inc NASDAQ:RMTI	USA	$21.57 Million
Inzi Display Co.Ltd KQ:037330	Korea	₩311.76 Billion
Eildon Capital Group AU:EDC	Australia	AU$9.78 Million
CPI Aerostructures Inc NYSE:CVU	USA	$49.07 Million
CNTus Sungjin Co. Ltd. KQ:352700	Korea	₩11.41 Billion
Sanatana Resources V:STA	Canada	CA$1.12 Million
Galaxia SM Inc KO:011420	Korea	₩10.56 Billion

Liability Composition Analysis (2015–2024)

This chart breaks down DongKoo Bio&Pharma Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see DongKoo Bio&Pharma Co. Ltd (006620) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.92	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.43	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.59	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how DongKoo Bio&Pharma Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for DongKoo Bio&Pharma Co. Ltd (2015–2024)

The table below shows the annual total liabilities of DongKoo Bio&Pharma Co. Ltd from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩138.73 Billion ≈ $94.01 Million	+72.00%
2023-12-31	₩80.66 Billion ≈ $54.66 Million	+15.30%
2022-12-31	₩69.95 Billion ≈ $47.41 Million	+27.97%
2021-12-31	₩54.66 Billion ≈ $37.04 Million	+9.98%
2020-12-31	₩49.70 Billion ≈ $33.68 Million	+5.58%
2019-12-31	₩47.07 Billion ≈ $31.90 Million	+46.28%
2018-12-31	₩32.18 Billion ≈ $21.81 Million	-14.97%
2017-12-31	₩37.85 Billion ≈ $25.65 Million	-12.52%
2016-12-31	₩43.27 Billion ≈ $29.32 Million	-25.69%
2015-12-31	₩58.22 Billion ≈ $39.46 Million	--

About DongKoo Bio&Pharma Co. Ltd

KQ:006620 Korea Pharmaceuticals

Market Cap

$26.72 Million

₩39.42 Billion KRW

Market Cap Rank

#24206 Global

#1681 in Korea

Share Price

₩4105.00

Change (1 day)

+0.12%

52-Week Range

₩3800.00 - ₩6090.00

All Time High

₩13745.55